A research team led by Professor Simona Giunta at the University of Rome La Sapienza has produced the first reference-quality ...
Dr Maja Petkovic commented “The first FDA approved treatments were CAR-T cells directed against the B cell protein CD19. This ...
WuXi Biologics, a global CRDMO, has launched TrueSite TI, a targeted integration (TI)-based CHO cell line platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback